Cardiovascular risk prediction - now and the future

Ian M Graham
Department of Cardiology, Trinity College Dublin, Ireland


Current cardiovascular risk estimation systems that estimate 10-year risk based on cohort studies starting at around age 40 have probably reached their limits based on current methods.
The challenges are to develop new systems that will permit personalised risk estimation earlier in life with better estimates of true lifetime risk and likely treatment benefits. We outline approaches to address these issues.


  1. De Backer G. New insights in cardiovascular risk estimation and stratification. e-Journal of Cardiology Practice 2022; 22.
  2. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42:3227-337.
  3. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41:111-88.
  4. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021; 42:2439-54.
  5. SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 2021; 42:2455-67.
  6. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140:e596-e646.
  7. Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart Association's PREVENT Equations. Circulation 2024; 149:430-49.
  8. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017; 38:2459-72.
  9. Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol 2018; 72:1141-56.
  10. Vardas PE, Vardas EP, Tzeis S. Medicine at the dawn of the metaclinical era. Eur Heart J 2023; 44:4729-30.
  11. Hunter DJ, Holmes C. Where Medical Statistics Meets Artificial Intelligence. N Engl J Med 2023; 389:1211-9.
  12. Lea AS, Jones DS. Mind the Gap - Machine Learning, Dataset Shift, and History in the Age of Clinical Algorithms. N Engl J Med 2024; 390:293-5.
  13. Liu W, Laranjo L, Klimis H, et al. Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 2023; 9:310-22.
  14. Ardissino M, Morley AP, Slob EAW, et al. Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association. Eur Heart J 2024; 45:443-54.

Send mail to Author

Send Cancel

Custom technologies based on your needs

  • MongoDB
  • ElasticSearch
  • Redis
  • Solr
  • Memcached